Back to Oklahoma

HB1389 • 2026

Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.

Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Provenzano
Last action
2025-05-29
Official status
Filed with Secretary of State
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.

Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.

What This Bill Does

  • Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.
  • Bill Summaries/Fiscal Impact for HB 1389 (House): Introduced (2/5/2025) Bill Summaries/Fiscal Impact for HB 1389 (House): Proposed Policy Committee Substitute 1 (2/5/2025) Bill Summaries/Fiscal Impact for HB 1389 (House): Proposed Policy Committee Recommendation (3/4/2025) Bill Summaries/Fiscal Impact for HB 1389 (House): Committee Substitute (3/7/2025)

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Plain English: Req.

  • Req.
  • No.
  • 12409 Page 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) POLICY COMMITTEE RECOMMENDATION FOR HOUSE BILL NO.
  • 1389 By: Provenzano POLICY COMMITTEE RECOMMENDATION An Act relating to mammography screening; amending 36 O.S.

Plain English: HB1389 POLPCS1 Melissa Provenzano-TJ 2/5/2025 9:01:26 am AMEND TITLE TO CONFORM TO AMENDMENTS Amendment submitted by: Melissa Provenzano Adopted: _____________________________ ______________________________________ Reading Clerk COMMITTEE AMENDMENT HOUSE OF REPRESENTATIVES State of Oklahoma SPEAKER: CHAIR: I move to amend HB1389 Of the printed Bill Page Section Lines Of the Engrossed Bill By deleting the content of the entire measure, and by inserting in lieu thereof the following language: Req.

  • HB1389 POLPCS1 Melissa Provenzano-TJ 2/5/2025 9:01:26 am AMEND TITLE TO CONFORM TO AMENDMENTS Amendment submitted by: Melissa Provenzano Adopted: _____________________________ ______________________________________ Reading Clerk COMMITTEE AMENDMENT HOUSE OF REPRESENTATIVES State of Oklahoma SPEAKER: CHAIR: I move to amend HB1389 Of the printed Bill Page Section Lines Of the Engrossed Bill By deleting the content of the entire measure, and by inserting in lieu thereof the following language: Req.
  • No.
  • 12404 Page 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) PROPOSED POLICY COMMITTEE SUBSTITUTE FOR HOUSE BILL NO.
  • 1389 By: Provenzano PROPOSED POLICY COMMITTEE SUBSTITUTE An Act relating to mammography screening; amending 36 O.S.

Bill History

  1. 2025-05-29 House

    Veto overridden: Ayes: 83 Nays: 3

  2. 2025-05-29 House

    To Senate

  3. 2025-05-29 Senate

    Veto overridden: Ayes: 42 Nays: 2

  4. 2025-05-29 Senate

    Measure returned to House

  5. 2025-05-29 House

    Filed with Secretary of State

  6. 2025-05-06 House

    Vetoed 05/06/2025

  7. 2025-04-30 House

    Enrolled, signed, to Senate

  8. 2025-04-30 Senate

    Enrolled measure signed, returned to House

  9. 2025-04-30 House

    Sent to Governor

  10. 2025-04-29 Senate

    Coauthored by Representative Stewart

  11. 2025-04-29 Senate

    General Order, Considered

  12. 2025-04-29 Senate

    Measure passed: Ayes: 34 Nays: 11

  13. 2025-04-29 Senate

    Engrossed measure signed, returned to House

  14. 2025-04-29 House

    Referred for enrollment

  15. 2025-04-09 Senate

    Placed on General Order

  16. 2025-04-09 Senate

    Coauthored by Senator Nice

  17. 2025-04-07 Senate

    Reported Do Pass Health and Human Services committee; CR filed

  18. 2025-04-01 Senate

    Second Reading referred to Health and Human Services

  19. 2025-03-24 Senate

    Coauthored by Representative Adams

  20. 2025-03-11 House

    Engrossed, signed, to Senate

  21. 2025-03-11 Senate

    First Reading

  22. 2025-03-11 Senate

    Coauthored by Representative Dobrinski

  23. 2025-03-11 Senate

    Coauthored by Representative Pittman

  24. 2025-03-11 Senate

    Coauthored by Representative Pae

  25. 2025-03-10 House

    General Order

  26. 2025-03-10 House

    Coauthored by Representative(s) Stark, Miller, Ranson, CrosswhiteHader, Townley, Schreiber, Hefner, Menz, West (Tammy), Munson, Gise, Cantrell, Bashore, Manger, Banning, Lowe (Dick)

  27. 2025-03-10 House

    Third Reading, Measure passed: Ayes: 95 Nays: 0

  28. 2025-03-10 House

    Referred for engrossment

  29. 2025-03-05 House

    CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee

  30. 2025-02-05 House

    Policy recommendation to the Health and Human Services Oversight committee; Do Pass, amended by committee substitute Public Health

  31. 2025-02-05 House

    Coauthored by Representative(s) Roe

  32. 2025-02-05 House

    Authored by Senator Stanley (principal Senate author)

  33. 2025-02-04 House

    Second Reading referred to Health and Human Services Oversight

  34. 2025-02-04 House

    Referred to Public Health

  35. 2025-02-03 House

    First Reading

  36. 2025-02-03 House

    Authored by Representative Provenzano

Official Summary Text

Mammography screening; coverage for low-dose mammography screening; examinations; definition; effective date.
Bill Summaries/Fiscal Impact for HB 1389 (House): Introduced (2/5/2025)
Bill Summaries/Fiscal Impact for HB 1389 (House): Proposed Policy Committee Substitute 1 (2/5/2025)
Bill Summaries/Fiscal Impact for HB 1389 (House): Proposed Policy Committee Recommendation (3/4/2025)
Bill Summaries/Fiscal Impact for HB 1389 (House): Committee Substitute (3/7/2025)

Current Bill Text

Read the full stored bill text
An Act
ENROLLED HOUSE
BILL NO. 1389 By: Provenzano, Roe, Stark,
Miller, Ranson, Crosswhite
Hader, Townley, Schreiber,
Hefner, Menz, West (Tammy),
Munson, Gise, Cantrell,
Bashore, Manger, Banning,
Lowe (Dick), Dobrinski,
Pittman, Pae, Adams, and
Stewart of the House

and

Stanley and Nice of the
Senate

An Act relating to mammography screening; amending 36
O.S. 2021, Section 6060, as amended by Section 1,
Chapter 294, O.S.L. 2022 (36 O.S. Supp. 2024, Section
6060), which relates to coverage for low-dose
mammography screening; adding new types of
examinations; defining term; and providing an
effective date.

SUBJECT: Mammography screening

BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:

SECTION 1. AMENDATORY 36 O.S. 2021, Section 6060, as
amended by Section 1, Chapter 294, O.S.L. 2022 (36 O.S. Supp. 2024,
Section 6060), is amended to read as follows:

Section 6060. A. For the purposes of this section:

1. "Breast magnetic resonance imaging" means a diagnostic tool
used to produce detailed pictures of the structure of the breast;

ENR. H. B. NO. 1389 Page 2
2. "Breast ultrasound" means a noninvasive, diagnostic imaging
technique that uses high-frequency sound waves to produce detailed
images of the breast;

3. "Diagnostic examination for breast cancer" means a medically
necessary and clinically appropriate examination, as defined by
current guidelines and as determined by a clinician who is
evaluating the individual for breast cancer, to evaluate the
abnormality in the breast that is:

a. seen or suspected from a screening examination for
breast cancer,

b. detected by another means of examination, or

c. suspected based on the medical history or family
medical history of the individual.

This examination may include, but is not limited to, a contrast–
enhanced mammogram, diagnostic mammogram, breast magnetic resonance
imaging, or a breast ultrasound, or molecular breast imaging;

4. "Diagnostic mammography" means a diagnostic tool that:

a. uses X-ray, and

b. is designed to evaluate abnormality in a breast;

5. "Health benefit plan" means any plan or arrangement as
defined in subsection C of Section 6060.4 of this title;

6. "Low-dose mammography" means:

a. the X-ray examination of the breast using equipment
specifically dedicated for such purpose, with an
average radiation exposure delivery of less than one
rad mid-breast and with two views for each breast,

b. digital mammography, or

c. breast tomosynthesis;

7. "Breast tomosynthesis" means a radiologic mammography
procedure involving the acquisition of projection images over a
stationary breast to produce cross-sectional digital three-
ENR. H. B. NO. 1389 Page 3
dimensional images of the breast from which breast cancer screening
diagnoses may be made; and

8. "Screening mammography" means a radiologic procedure
provided to a woman, who has no signs or symptoms of breast cancer,
for the purpose of early detection of breast cancer, including
breast tomosynthesis; and

9. "Supplemental examination" means a medically necessary and
appropriate examination of the breast, including, but not limited
to, such an examination using contrast–enhanced mammography, breast
magnetic resonance imaging, breast ultrasound, or molecular breast
imaging that is:

a. used to screen for breast cancer when there is no
abnormality seen or suspected, and

b. based on personal or family medical history or
additional factors that increase the individual's risk
of breast cancer, including heterogeneously or
extremely dense breasts.

B. All health benefit plans shall include the coverage
specified by this section for a low-dose mammography screening for
the presence of occult breast cancer and a diagnostic and
supplemental examination for breast cancer. Such coverage shall
not:

1. Be subject to the policy deductible, co-payments and co-
insurance limits of the plan; or

2. Require that a female undergo a mammography screening at a
specified time as a condition of payment.

C. 1. Any female thirty-five (35) through thirty-nine (39)
years of age shall be entitled pursuant to the provisions of this
section to coverage for a low-dose mammography screening once every
five (5) years.

2. Any female forty (40) years of age or older shall be
entitled pursuant to the provisions of this section to coverage for
an annual low-dose mammography screening.

D. If application of this act would result in health savings
account ineligibility under Section 223 of the federal Internal
ENR. H. B. NO. 1389 Page 4
Revenue Code, as amended, the provisions of this section shall only
apply to health savings accounts with qualified high deductible
health plans with respect to the deductible of such a plan after the
enrollee has satisfied the minimum deductible. Provided, however,
the provisions of this section shall apply to items of services that
are preventive care pursuant to Section 223(c)(2)(c) of the federal
Internal Revenue Code, as amended, regardless of whether the minimum
deductible has been satisfied.

SECTION 2. This act shall become effective November 1, 2025.

ENR. H. B. NO. 1389 Page 5
Passed the House of Representatives the 10th day of March, 2025.

Presiding Officer of the House
of Representatives

Passed the Senate the 29th day of April, 2025.

Presiding Officer of the Senate

OFFICE OF THE GOVERNOR
Received by the Office of the Governor this ____________________
day of ___________________, 20_______, at _______ o'clock _______ M.
By: _________________________________
Approved by the Governor of the State of Oklahoma this _________
day of ___________________, 20_______, at _______ o'clock _______ M.

_________________________________
Governor of the State of Oklahoma

OFFICE OF THE SECRETARY OF STATE
Received by the Office of the Secretary of State this __________
day of ___________________, 20_______, at _______ o'clock _______ M.
By: _________________________________